MedElevator
Войти в исследования Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mok Yejin, Surapaneni Aditya, Sang Yingying, Coresh Josef, Grams Morgan E, Matsushita Kunihiro, Ballew Shoshana H, Alencar de Pinho Natalia, Ärnlöv Johan, Barreto Sandhi M, Bell Samira, Brenner Hermann, Carrero Juan-Jesus, Chinnadurai Rajkumar, Ciemins Elizabeth, Gansevoort Ron T, Jassal Simerjot K, Jung Keum Ji, Kirchner H Lester, Konta Tsuneo, Kovesdy Csaba P, Luo Li, Pandit Krutika, Rahman Mahboob, Robinson-Cohen Cassianne, Sabanayagam Charumathi, Schultheiss Ulla T, Shlipak Michael, Staplin Natalie, Tonelli Marcello, Wang Angela Yee-Moon, Wen Chi-Pang, Woodward Mark, Lees Jennifer S, CKD Prognosis Consortium
Аннотация
METHODS: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.
RESULTS: Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.
DISCUSSION: Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.